| |
| Issue |
Title |
| |
| No 19 (2019) |
Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case |
Abstract
PDF (Rus)
|
|
E. V. Glazkova, M. A. Frolova, M. B. Stenina |
| |
| No 19 (2019) |
Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study |
Abstract
PDF (Rus)
|
|
I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin |
| |
| No 10 (2019) |
Nab-paclitaxel monotherapy in patients with metastatic breast cancer with visceral crisis: evaluation of efficacy and tolerability in clinical practice |
Abstract
PDF (Rus)
|
|
L. Yu. Vladimirova, K. A. Novoselova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, L. A. Ryadinskaya, A. A. Lyanova, M. O. Ezhova, M. A. Teplyakova, A. A. Tishina, E. V. Prikhodko |
| |
| No 19 (2018) |
Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer |
Abstract
PDF (Rus)
|
|
N. V. Dobrova, E. I. Borisova, A. D. Darenskaya |
| |
| No 19 (2018) |
Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer |
Abstract
PDF (Rus)
|
|
A. A. Tryakin, P. A. Balunov |
| |
| No 19 (2018) |
Nab-paclitaxel in the treatment of breast cancer: clinical trial data and first-hand experience |
Abstract
PDF (Rus)
|
|
E. I. Borisova, S. P. Gutorov, G. V. Vyshinskaya, N. V. Dobrova, M. E. Abramov |
| |
| No 19 (2018) |
Ixabepilone: new perspectives for its use in breast cancer |
Abstract
PDF (Rus)
|
|
A. A. Mescheryakov, E. V. Lubennikova, M. E. Abramov |
| |
| No 19 (2018) |
Clinical case of long-term pemetrexed-based chemotherapy treatment for pulmonary adenocarcinoma (ALA +) |
Abstract
PDF (Rus)
|
|
A. M. Lozhkina, M. A. Sviridenko, A. O. Cheremnykh, E. A. Filippova, M. A. Urtenova, S. V. Odintsova, S. V. Orlov |
| |
| No 10 (2018) |
The prospects for cisplatin and nab-paclitaxel combination therapy in patients with pre-treated triple-negative breast cancer. Description of the clinical case. |
Abstract
PDF (Rus)
|
|
L. G. Zhukova, K. S. Bardovskaya, E. V. Lubennikova, I. R. Suslova |
| |
| No 10 (2018) |
Cytotoxic therapy: from past to future |
Abstract
PDF (Rus)
|
|
article editotial |
| |
| No 14 (2017) |
СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ТЕРАПИИ КОЛОРЕКТАЛЬНОГО РАКА |
Abstract
PDF (Rus)
|
|
|
| |
| No 14 (2017) |
CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES |
Abstract
PDF (Rus)
|
|
N. V. Dobrova, O. O. Gordeeva, E. V. Chernoglazova, A. A. Tryakin |
| |
| No 6 (2017) |
NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES |
Abstract
PDF (Rus)
|
|
T. Y. SEMIGLAZOVA, V. A. KLYUGE, E. A. KOROBEYNIKOVA, P. V. KRIVOROTKO, R. M. PALTUEV, G. M. TELETAEVA, D. H. LATIPOVA, V. V. KLIMENKO, E. V. TACHENKO, A. V. Novik, A. I. SEMENOVA, V. V. SEMIGLAZOV, S. A. PROTSENKO, V. F. SEMIGLAZOV |
| |
| No 6 (2017) |
TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER |
Abstract
PDF (Rus)
|
|
O. O. GORDEEVA, M. E. ABRAMOV, A. N. LUD |
| |
| No 6 (2017) |
CHEMOTHERAPY BREAST CANCER MODERN VIEW ON THE PROBLEM |
Abstract
PDF (Rus)
|
|
V. F. SEMIGLAZOV, V. A. GORBUNOVA, S. A. TYULYANDIN |
| |
| No 6 (2017) |
COMBINATION CHEMOTHERAPY REGIMENS IN PANCREATIC CANCER |
Abstract
PDF (Rus)
|
|
A. S. POPOVA, I. A. POKATAEV, S. A. TYULYANDIN, |
| |
| 1 - 16 of 16 Items |
|
